Quoted from http://www.reuters.com/article/2011/06/23/takeda-idUSL3E7HN2J820110623
EU delays verdict on Takeda diabetes drug to July
Thu Jun 23, 2011 12:08pm EDT
LONDON, June 23 (Reuters) - European regulators on Thursday put back a decision until July on whether Takeda Pharmaceutical's diabetes drug Actos should remain on the market or not due to a possible link to bladder cancer.
The European Medicines Agency (EMA), which had been due to deliver a verdict this week, said there were "still numerous issues that needed to be resolved" before it could make a recommendation on the drug's future use.
It will finalise its recommendation at the next monthly meeting of its experts in July.